118 related articles for article (PubMed ID: 32248980)
1. Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.
Abudurexiti Y; Gu Z; Chakma K; Hata T; Motoi F; Unno M; Horii A; Fukushige S
Biochem Biophys Res Commun; 2020 Jun; 526(3):626-632. PubMed ID: 32248980
[TBL] [Abstract][Full Text] [Related]
2. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer.
Chakma K; Gu Z; Abudurexiti Y; Hata T; Motoi F; Unno M; Horii A; Fukushige S
Cancer Sci; 2020 Dec; 111(12):4594-4604. PubMed ID: 32894817
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/β-catenin and P53 signaling pathways.
Chen HQ; Zhao J; Li Y; Huang YJ; Chen DJ; He LX; Wang LQ; Zheng CF; Wang J; Cao J; Shu WQ; Liu JY; Liu WB
Environ Pollut; 2019 Sep; 252(Pt A):216-226. PubMed ID: 31151060
[TBL] [Abstract][Full Text] [Related]
5. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway.
Hu Z; Xie L
Mol Med Rep; 2015 Sep; 12(3):4634-4639. PubMed ID: 26129710
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review.
Nathalia E; Theardy MS; Elvira S; Rosellinny G; Liyanto AS; Utama MP; Sumarpo A
Rom J Intern Med; 2018 Sep; 56(3):135-142. PubMed ID: 29533904
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor LHX6 upregulation contributes to the inhibitory effect of miR-346 knockdown on colorectal cancer cell growth.
Li X; Zhou Y; Wen P; Yuan Y; Xiao Z; Shi H; Zhou H
Environ Toxicol; 2022 Mar; 37(3):435-445. PubMed ID: 34773443
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells.
Wu TH; Chang SY; Shih YL; Chian CF; Chang H; Lin YW
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751497
[TBL] [Abstract][Full Text] [Related]
9. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
11. Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activation" (MeTA-array).
Shimizu H; Horii A; Sunamura M; Motoi F; Egawa S; Unno M; Fukushige S
Biochem Biophys Res Commun; 2011 Jul; 411(1):162-7. PubMed ID: 21723258
[TBL] [Abstract][Full Text] [Related]
12. The exon 12-containing LHX6 isoforms promote cervical cancer cell proliferation by regulating the MAPK signaling pathway.
Wang L; Zhou Y; Cao C; Lin S; Zhi W; Zhang D; Li J; Wei R; Jiang G; Xu H; Wang X; Xi L; Wu P
Cancer Med; 2022 Oct; 11(19):3657-3673. PubMed ID: 35384355
[TBL] [Abstract][Full Text] [Related]
13.
Dangoni GD; Teixeira ACB; Vince CSC; Novak EM; Gimenez TM; Maschietto M; Odone Filho V; Krepischi ACV
J Dev Orig Health Dis; 2023 Feb; 14(1):140-145. PubMed ID: 36154949
[TBL] [Abstract][Full Text] [Related]
14. Lhx6 and Lhx8: cell fate regulators and beyond.
Zhou C; Yang G; Chen M; He L; Xiang L; Ricupero C; Mao JJ; Ling J
FASEB J; 2015 Oct; 29(10):4083-91. PubMed ID: 26148970
[TBL] [Abstract][Full Text] [Related]
15. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
[TBL] [Abstract][Full Text] [Related]
16. The LIM homeodomain transcription factor LHX6: a transcriptional repressor that interacts with pituitary homeobox 2 (PITX2) to regulate odontogenesis.
Zhang Z; Gutierrez D; Li X; Bidlack F; Cao H; Wang J; Andrade K; Margolis HC; Amendt BA
J Biol Chem; 2013 Jan; 288(4):2485-500. PubMed ID: 23229549
[TBL] [Abstract][Full Text] [Related]
17. MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6.
Yan L; Cai K; Sun K; Gui J; Liang J
J Cell Physiol; 2018 Oct; 233(10):6621-6629. PubMed ID: 29226322
[TBL] [Abstract][Full Text] [Related]
18. Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2.
Cesario JM; Landin Malt A; Deacon LJ; Sandberg M; Vogt D; Tang Z; Zhao Y; Brown S; Rubenstein JL; Jeong J
Hum Mol Genet; 2015 Sep; 24(17):5024-39. PubMed ID: 26071365
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
Xu S; Furukawa T; Kanai N; Sunamura M; Horii A
J Hum Genet; 2005; 50(4):159-167. PubMed ID: 15824892
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
